Ellevest, Inc. Gritstone Bio, Inc. Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$1.77 - $4.34 $295 - $724	-167 Reduced 95.98%	7 $0
Q4 2020 Feb 04, 2021	BUY	$2.57 - $4.22 $33 - $54	13 Added 8.07%	174 $1,000
Q3 2020 Oct 26, 2020	BUY	$2.63 - $8.09 $423 - $1,302	161 New	161 $0
Q2 2020 Jul 06, 2020	SELL	$5.69 - $8.17 $68 - $98	-12 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$5.47 - $11.3 $65 - $135	12 New	12 $0

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.